ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | -70.9% | 115,006 | -64.4% | 0.00% | – |
| Q1 2022 | $230,000 | -81.8% | 323,397 | -66.2% | 0.00% | -100.0% |
| Q4 2021 | $1,262,000 | -57.9% | 956,258 | -26.7% | 0.00% | -66.7% |
| Q3 2021 | $3,001,000 | -47.6% | 1,304,651 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $5,727,000 | -39.5% | 1,304,651 | 0.0% | 0.01% | -40.0% |
| Q1 2021 | $9,472,000 | +382.0% | 1,304,651 | +186.8% | 0.01% | +400.0% |
| Q4 2020 | $1,965,000 | +5.1% | 454,934 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,870,000 | -31.5% | 454,934 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $2,730,000 | -20.3% | 454,934 | 0.0% | 0.00% | -40.0% |
| Q1 2020 | $3,426,000 | -45.2% | 454,934 | 0.0% | 0.01% | -28.6% |
| Q4 2019 | $6,255,000 | +74.4% | 454,934 | +50.7% | 0.01% | +40.0% |
| Q3 2019 | $3,586,000 | -15.1% | 301,880 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $4,223,000 | – | 301,880 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |